Clearance of HSV-2 from Recurrent Genital Lesions Correlates with Infiltration of HSV-specific Cytotoxic T Lymphocytes
Overview
Affiliations
The mechanisms involved in host clearance of symptomatic mucocutaneous herpes simplex virus (HSV) infection are unclear. We studied the functional properties of bulk cultures of skin-infiltrating lymphocytes from normal skin and serial biopsies of recurrent genital HSV-2 lesions, and compared HSV-specific and NK responses with viral clearance. HSV-specific CD4+ or CD8+ T cells were rarely detected in lymphocytes cultured from normal skin. The total lymphocyte count and HSV-specific and NK-like effector cell activities were markedly higher in cultures derived from lesional skin. HSV-specific CD4+ proliferative responses and NK-like cytotoxic responses were present at all stages of herpetic lesions, including biopsies early in the disease course. In contrast, cytotoxic T lymphocyte activity was generally low among cells derived from early culture-positive lesions, and increased during lesion evolution. Viral clearance from the lesion site was associated with a high level of local cytolytic activity towards HSV-infected cells. The phenotypes of cells with HSV-specific cytotoxic responses varied between patients, having CD4+ and CD8+ components. Immunotherapeutic approaches to HSV should be directed at improving in vivo cytolytic activity to HSV.
Rossetti E, Vujadinovic M, van Huizen E, Tolboom J, Schuitemaker H, Yao F PLoS One. 2024; 19(12):e0310250.
PMID: 39739963 PMC: 11687876. DOI: 10.1371/journal.pone.0310250.
Mian M, Pa S, Rahman N, Gillgrass A, Kaushic C Front Immunol. 2024; 15:1427842.
PMID: 39569191 PMC: 11576457. DOI: 10.3389/fimmu.2024.1427842.
A review of HSV pathogenesis, vaccine development, and advanced applications.
Bai L, Xu J, Zeng L, Zhang L, Zhou F Mol Biomed. 2024; 5(1):35.
PMID: 39207577 PMC: 11362470. DOI: 10.1186/s43556-024-00199-7.
Towards a comprehensive view of the herpes B virus.
Lu J, Long Y, Sun J, Gong L Front Immunol. 2023; 14:1281384.
PMID: 38035092 PMC: 10687423. DOI: 10.3389/fimmu.2023.1281384.
Bourne N, Keith C, Miller A, Pyles R, Cohen G, Milligan G J Virol. 2023; 97(9):e0066923.
PMID: 37655939 PMC: 10537585. DOI: 10.1128/jvi.00669-23.